Cytomegalovirus infection and vessel wall pathology

Intervirology

Volumn 39, Issue 3, 1996, Pages 213-221

  Van Dam Mieras, Maria C E ^a   Bruggeman, Cathrien A ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b OPEN UNIVERSITY OF THE NETHERLANDS   (Netherlands)

Author keywords

CMV latency; Inflammatory response; NF B activation; Restenosis; Smooth muscle cell proliferation; Transplant associated arteriosclerosis; Vascular cell activation

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

BLOOD VESSEL WALL; CELL ACTIVATION; CEREBROSPINAL FLUID; CYTOMEGALIC INCLUSION BODY DISEASE; HUMAN; HUMAN CYTOMEGALOVIRUS; INFLAMMATION; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; RESTENOSIS; REVIEW; SMOOTH MUSCLE; VASCULAR DISEASE;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 0030485313     PISSN: 03005526     EISSN: 14230100     Source Type: Journal    
DOI: 10.1159/000150497     Document Type: Article

References (129)

1. DcMarchi JM, Blankenship ML, Brown GD, Kaplan AS: Size and complexity of human cytomegalovirus DNA, Virology 1978:89:643- 646.
2. Kilpatrick BA, Huang ES: Human cytomegalovirus genome: Partial denaturation map and organization of genome sequences, J Virol 1977;24:261-276.
3. Chec MS, Bankier AT, Beck S, Bohni R, Brown CM, Cemy R, Horsncll T, Hutchison CAD, Kouzarides T, Marlignetti JA, et al: Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD 196. Cun-Top Microbiol Immunol 1990:154:125-169.
4. Wathen MW, Stinski MF: Temporal patterns of human cytomegalovirus transcription: Mapping the viral RNAs synthesized at immediate early, early, and late times after infection, J Virol 1982:41:462-477.
5. Melnick JL, Petrie BL, Drccsman GR, Burck J, McCollum CH, DcBakcv ME: Cytomegalovirus antigen within human arterial smooth muscle cells, Lancet 1983;2:644-647.
6. Gvorkey F, Melnick JL, Guinn GA, Gyorkey P, DeBakey ME: Hcrpcsviridae in the endothelial and smooth muscle cells of the proximal aorta in arteriosclerotic patients, Exp Mol Pathol 1984;40:328-339.
7. Petrie BL, Melnick JL, Adam E, Burek J, McCollum CH, DeBakey ME: Nucleic acid sequences of cytomegalovirus in cells cultured from human arterial tissue, J Infect Dis 1987; 155:158-159.
8. Yamashiroya HM, Ghosh L, Yang R, Robertson AL Jr.: Hcrpcsviridae in the coronary arteries and aorta of young trauma victims, Am J Pathol 1988:130:71-79.
9. Hendrix MG, Donnans PH, Kitslaar P, Bosnian F, Bruggeman CA: The presence of cytomegalovirus nucleic acids in arterial walls of atherosclerotic and nonatherosclerotic patients, Am J Pathol 1989:134:1151-1157.
10. Hendrix MG, Salimans MM, van Boven CP, Bruggeman CA: High prevalence of latently present cytomegaloviurs in arterial walls of patients suffering from grade III atherosclerosis, Am J Pathol 1990;136:23-28.
11. Adam E, Melnick JL, Probtsfield JL, Petrie BL, Burek J, Bailey KR, McCollum CH, DeBakey ME: High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis, Lancet 1987;2:291 -293.
12. Span AH, Frcdcrik PM, Grauls G, Van Boven GP, Bruggeman CA: CMV induced vascular injury: An electron-microscopic study in the rat, In Vivo 1993;7:567-573.
13. Span AH, Grauls G, Bosnian F, van Boven CP, Bruggcman CA: Cytomegalovirus infection induces vascular injury in the rat, Atherosclerosis 1992;93:41-52.
14. Ross R: The pathogenesis of atherosclerosis -An update, N Engl J Med 1986:314:488-500.
15. Bruggcman CA, Van Dam-Mieras MCE: The possible role of cytomegalovirus in athcrogcne-sis: in Melnick JL (cd): Prog Med Virol, Basel, Kargcr, 1991. vol 38. pp 1-26.
16. Spcir E, Modali R, Huang ES, Leon MB, Shawl F, Finkel T, Epstein SE: Potential role of human cytomegalovirus and p53 interaction in coronary restcnosis, Science 1994:265:381-384.
17. Billingham ME: Histopathology of graft coronary disease, J Heart Lung Transplant 1992:11: S38-S44.
18. Gao SZ, Schrocdcr JS, Hunt S, Stinson EB: Rctransplanlation for severe accelerated coronary artery disease in heart transplant recipients, Am J Cardiol 1988;62:876-881.
19. Olivari MT, Homans DC, Wilson RF, Kubo SH, Ring WS: Coronary artery disease in cardiac transplant patients receiving triple-drug immunosuppressive therapy, Circulation 1989:80:111-115.
20. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PF, Stinson FB, Shumway NE: Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis, JAMA 1989;261:3561-3566.
21. McDonald K, Rector TS, Braulin EA, Kubo SH, Olivari MT: Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection, Am J Cardiol 1989: 64:359-362.
22. Iocbe M, Schuler S, Zais O, Warnccke H, Fleck E, Hetzer R: Role of cytomegalovirus infection in the development of coronary artery disease in the transplanted heart, J Heart Transplant 1990:9:707-711.
23. Koskinen PK, Niemincn MS, Krogcrus LA, Lemstrom JB, Mattila SP, Hayry PJ, Lau-tenschlager IT: Cytomegalovirus infection and accelerated cardiac allograft vasculopathy in human cardiac allografts, J Heart Lung Transplant 1993:12:724-729.
24. Lemstrom KB, Bruning JH, Bruggeman CA, Lautcnschlager IT, Hayry PJ: Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts, J Clin Invest 1993:92:549-558.
25. Lemstrom K, Persoons M, Bruggeman C, Ustinov J, Laulenschlager 1. Hayry P: Cytomegalovirus infection enhances allograft arteriosclerosis in the rat, Transplant Proc 1993:25:1406- 1407.
26. Li F, Grauls G, Yin M, Bruggeman CA: Initial endothelial injury and cytomegalovirus infection accelerate the development of allograft arteriosclerosis, Transplant Proc 1995:27: 3552-3554.
27. Bruggeman CA, Li F, Stals FS: Pathogenicity: Animal models, Scand J Infect Dis 1995;599: 43-50.
28. Hävry PJ, Isonicmi H, Yilmaz S, Mcnnander A, Lemstrom K, Räisäncn-Sokolowski A, Koskinen P, Ustinov J, Lautenschlager I, Taskincn E, Krogcrus L, Aho P, Paavonen T: Chronic allograft rejection, Immunol Rev 1993:134:33- 81.
29. van Dam-Mieras MCE, Niesink RJM, Sloep PB: Strategics to survive; in Counotte A, Leach CK, van Dam-Mieras MCE (eds): Defence Mechanisms, Oxford, Buttcrworth Heine-mann, 1993. pp 2-27.
30. Roitt I: Essential immunology, Oxford, Black-well, 1982.
31. Weber G, Bianciardi G, Toti P, Resi L, Tanga-nelli P: Some pathogenetic aspects of atherosclerotic lesions, Platelets and athcrogcnesis, Differences in atherogenesis in different body districts, Regression of arterial lesions in animal models, Int Angiol 1987:6:37-43.
32. Schwartz CJ, Valente AJ, Sprague EA, Kelley JI Suenram CA, Graves DT, Rozek MM, Edwards EH, Delgado R: Monocvte-macrophagc participation in atherogenesis: Inflammatory components of pathogenesis, Semin Thromb Hemost 1986:12:79-86.
33. Virclla G, Lopes Virclla MF: Infections and atherosclerosis, Transplant Proc 1987; 19:26- 35.
34. Halliwell B, Hoult JR, Blake DR: Oxidants, inflammation, and anti-inflammatory drugs, FasebJ 1988:2:2867-2873.
35. Cotran RS: American Association of Pathologists president's address, New roles for the endothelium in inflammation and immunity, Am J Pathol 1987;129:407-413.
36. Harlan JM: Consequences of leukocytc-vcssel wall interactions in inflammatory and immune reactions, Semin Thromb Hemost 1987:13: 434-444.
37. Moncada S, Radomski MW, Palmer RM: Endothelium-derived relaxing factor, Identification as nitric oxide and role in the control of vascular tone and platelet function, Biochent Pharmacol 1988:37:2495-2501.
38. Pobcr JS, Cotran RS: The role of endothelial cells in inflammation, Transplantation 1990; 50:537-544.
39. Hajjar DP, Pomcrantz KB: Signal transduction in atherosclerosis: Integration of cytokines and thecicosanoid network, Fase bJ 1992:6:2933- 2941.
40. SchleifTcnbaum B, Fehr J: Regulation and selectivity of leukocyte emigration, J Lab Clin Med 1996:127:151-168.
41. Slavin J: The role of cytokines in wound healing, J Pathol 1996;178:5-10.
42. Harris ML, Schiller HJ, Reilly PM, Donowitz M, Grisham MB, Bulkley GB: Free radicals and other reactive oxygen metabolites in inflammatory bowel disease: Cause, consequence or epiphenomenon? Pharmacol Titer 1992:53: 375-408.
43. Vercellotti GM, Severson SP, Duane P, Mol-dow CF: Hydrogen peroxide alters signal transduction in human endothelial cells, J Lab Clin Med 1991:117:15-24.
44. Halliwell B, Guttcridge JM, Cross CE: Free radicals, antioxidants, and human disease: Where are we now? J Lab Clin Med 1992:119: 598-620.
45. Halliwell B, Gutteridge JM: The antioxidants of human extracellular fluids, Arch Biochem Biophys 1990:280:1-8.
46. Farbcr JL, Kyle ME: Coleman JB: Mechanisms of cell injury by activated oxygen species, Lab Invest 1990:62:670-679.
47. Wiseman H, Halliwell B: Damage to DNA by reactive oxygen and nitrogen species: Role in inflammatory disease and progression to cancer, Biochem J 1996:313:17-29.
48. Schreck R, Albermann K, Baeuerle PA: Nuclear factor kappa B: An oxidative stress-responsive transcription factor of eukaryotic cells (a review), Free Radic Res Commun 1992: 17:221-237.
49. Ho M: Cytomegalovirus: Biology and Infection, New York, Plenum, 1991.
50. Machcr AM, Reichert CM, Straus SE, Longo DL, Parrillo J, Lane HC, Fauci AS, Rook AH, Manischewitz JF, Quinnan GV Jr.: Death in the AIDS patient: Role of cytomegalovirus, N Engl J Med 1983:309:1454.
51. Jacobson MA, Mills J: Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS), Clinical findings, diagnosis, and treatment, Ann Intern Med 1988; 108:585- 594.
52. Gangan PA, Besen G, Munguia D, Freeman WR: Macular serous exudation in patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis, Am J Ophthalmol 1994:118:212-219.
53. Winston DJ, Ho WG, Lin CH, Bartoni K, Budingcr MD, Gale RP, Champlin RE: intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation, Ann Intern Med 1987;106:12-18.
54. Duncombe AS, Meager A, Prentice HG, Grundy JE, Hcslop HE, Hoffbrand AV, Brenner MK: Gamma-intcrferon and tumor necrosis factor production after bone marrow transplantation is augemented by exposure to marrow fibroblasts infected with cytomegalovirus, Blood 1990:76:1046-1053.
55. Dudding L, Haskill S, Clark BD, Auron PE, Sporn S, Huang ES: Cytomegalovirus infection stimulates expression of monocyte-associated mediator genes, J Immunol 1989; 143:3343- 3352.
56. Haagntans BL, van den Ecrtwegh AJ, Claasscn E, Horzinck MC, Schijns VE: Tumour necrosis factor-alpha production during cytomegalovirus infection in immunosuppressed rats, J Gen Virol 1994;75:779-787.
57. Iwamoto GK, Monich MM, Clark BD, Auron PE, Stinski MF: Hunninghakc GW: Modulation of interleukin I beta gene expression by the immediate early genes of human cytome-glovirus, J Clin Invest 1990:85:1853-1857.
58. Smith PD, Saini SS, Raffcld M, Manischewitz JF, Wahl SM: Cytomegalovirus induction of tumor necrosis factor-alpha by human monocytes and mucosal macrophages, J Clin Invest 1992;90:1642-1648.
59. Grundy JE, Shanlcy JD, Shearer GM: Augmentation of graft-versus-host reaction by cytomegalovirus infection resulting in interstitial pneumonitis, Transplantation 1985:39:548- 553.
60. Koskinen PK: The association of the induction of vascular cell adhesion molecule-1 with cytomegalovirus antigencmia in human heart allografts, Transplantation 1993:56:1103-1108.
61. Hosenpud JD, Chou SW, Wagner CR: Cyto-mcgalovirus-enduced regulation of major histocompatibility complex class I antigen expression in human aortic smooth muscle cells, Transplantation 1991;52:896-903.
62. Keller RP, Peilchel JN, Goldman JN, Goldman M: An IgG-Fc receptor induced in cytomegalovirus-infected human fibroblasts, J Immunol 1976:116:772-777.
63. MacGregor RR, Friedman HM, Macarak EJ, Kefalidcs NA: Virus infection of endothelial cell increases granulocyte adherence, J Clin Invest 1980:65:1469-1477.
64. Fujinami RS, Nelson JA, Walker L, Oldstone MB: Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DR beta chain: A means for graft rejection and immunosuppression, J Virol 1988:62:100-105.
65. Beck S, Barrel! BG: Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens, Nature 1988:331:269-272.
66. Mvcrson D, Hackman RC, Nelson JA, McDoughall JK: Widespread presence of histologically occult cytomegalovirus, Hum Pathol 1984:15:430-438
67. Bruggeman CA, Debic WHM, Grauls G, Ma-joor G, Van Boven CPA: Infection of laboratory rats with a new cytomcgalo-like virus, Arch Virol 1983:76:189-199.
68. Bruggeman CA, Meijer H, Bosnian F, van Boven CP: Biology of rat cytomegalovirus infection, Intcrvirology 1985:24:1-9.
69. Simmons P, Kaushansky K, Torok Storb B: Mechanisms of cytomegalovirus-mediated myelosuppression: Perturbation of stromal cell function versus direct infection of myeloid cells, Proc Natl Acad Sei USA 1990;87:l386-1390.
70. Rinaldo CJ, Black PH, Hirsh MS: Interaction of cytomegalovirus with leukocytes from patients with mononucleosis due to cytomegalovirus, J Infect Dis 1977; 136:667-678.
71. Rice GPA, Schricr RD, Oldstone MBA: Cytomegalovirus infects human lymphocytes and monocytes: Virus expression is restricted to immediate-early gene products, Immunology 1984;81:6134-6138.
72. Maciejewski JP, Bruening EE, Donahue RE, Mocarski ES, Young NS, St Jeor SC: Infection of hematopoietic progenitor cells by human cytomegalovirus, Blood 1992:80:170-178.
73. Jordan MC: Latent infection and the elusive cytomegalovirus, Rev Infect Dis 1983:5:205-215.
74. Taylor HP, Cooper NR: Human cytomegalovirus binding to fibroblasts is receptor mediated, J Virol 1989:63:3991-3998.
75. Taylor HP, Cooper NR: The human cytomegalovirus receptor on fibroblasts is a 30-kilodal-ton membrane protein, J Virol 1990:64:2484-2490.
76. Adlish JD, Lahijani RS, St Jeor SC: Identification of a putative cell receptor for human cytomegalovirus, Virology 1990:176:337-345.
77. Nowlin DM, Cooper NR, Compton T: Expression of a human cytomegalovirus receptor correlates with infectibility of cells, J Virol 1991: 65:3114-3121.
78. Keav S, Merigan TC, Rasmussen L: Identification of cell surface receptors for the 86-kilodal-ton glycoprotein of human cytomegalovirus, Proc Natl Acad Sci USA 1989:86:10100-10103.
79. Soderbcrg C, Larsson S, Bcrgstedt-Linquist S, Moller F,: Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection, J Virol 1993:67:3166-3175.
80. Taylor Wicdcman J, Sissons JG, Borysiewicz LK, Sinclair JH: Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells, J Gen Virol 1991:72:2059-2064.
81. Kondo K, Kaneshima H, Mocarski ES: Human cytomegalovirus latent infection of granulocyte-macrophage progenitors, Proc Natl Acad Sci USA 1994:91:11879-11883.
82. Weinshenker BG, Wilton S, Rice GPA: Phor-bol ester-induced differentiation permits productive human cytomegaloviurs infection in a monocytic cell line, J Immunol 1988:140: 1625-1631.
83. Lathey JL, Spector SA: Unrestricted replication of human cytomegalovirus in hydrocortisone-treated macrophages, J Virol 1991:65: 6371-6375.
84. Taylor-Wiedeman J, Sissons P, Sinclair J: Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers, J Virol 1994: 68:1597-1604.
85. Grefte JMM, Van derGiessen M, Van Son WJ, The TH: Circulating human cytomegalovirus (HCMVj-infccted endothelial cells in patients with an active HCMV infection, J Infect Dis 1993;167:270-277.
86. Grefte JMM, Blom N, Van derGiessen M, Van Son WJ, The TH: Ultrastructural analysis of circulating cytomegalic cells in patients with active cytomegalovirus infection: Evidence for vims production and endothelial origin, J Infect Dis 1993:168:1110-1118.
87. Pcrsoons MCJ, Daemen MJAP, Bruiting JII, Bruggeman CA: Active cytomegalovirus infection of arterial smooth muscle cells in immunocompromised rats, A clue to herpesvirus-associated atherogenesis? Circ Res 1994:75:214- 220.
88. Tumilowicz JJ, Gawlik ME, Bowell PP, Tren-tin JJ: Replication of cytomegalovirus in human arterial smooth muscle cells, J Virol 1985; 56:839-845.
89. Banji A, Salisbury R: Cytomegalovirus and vasculitis, Br Med J 1978;1:623-624.
90. Roberts WEI, Sneddon JM, Waldntan J, Stephens RE: Cytomegalovirus infection of gastrointestinal endothelium demonstrated by simultaneous nucleic acid hybridization and immunohistochemistry, Arch Pathol Lab Med 1989:113:461-464.
91. Geclen AGM, Slobbe-van Drunen MEP, Muller AD, Bruggeman CA, van Dam-Mieras MCE: Membrane related elTects in endothelial cells induced by cytomegalovirus, Arch Virol 1995:140:1601 -1612.
92. Waldman WJ, Sneddon JM, Stephens RE, Roberts WH: Enhanced endothelial cytopa-thogenicity induced by a cytomegalovirus strain propagated in endothelial cells, J Med Virol 1989:28:223-230.
93. Vossen RCRM, Derhaag JG, Slobbe-van Drunen MEP, Duijvcstijn AM, van Dam-Mieras MCE, Bruggeman CA: A dual role for endothelial cells in cytomegalovirus cell lines, Virus Res, in press
94. Lathey JL, Wiley CA, Verity MA, Nelson JA: Cultured human brain capillary endothelial cells are permissive for infection by human cytomegalovirus, Virology 1990; 176:266- 273.
95. Bruggeman CA, Paavoncn T: Towards understanding the pathophysiology of chronic rejection, Clin Invest 1992:70:780-790.
96. Taraka H, Sukhova GK, Swanson SJ, Cybul-sky MI, Sehoen FJ, Libby P: Endothelial and smooth muscle cells express leukocyte adhesion molecules heterogeneously during acute rejection of rabbit cardiac allografts, Am J Pathol 1994;144:938-951.
97. Mannon RB, Sundar SK, Sanfilippo F, Coffman T: Alterations in renal interleukin-1 production during kidney transplant rejection in the rat, Transplantation 1993:56:1157-1162.
98. Gille J, Swerlick RA, Lawley TJ, Caughman SW: Differential regulation of vascular cell adhesion molecule-1 gene transcription by tumor necrosis factor alpha and interleukin-1 alpha in dermal microvascular endothelial cells, Blood 1996:87:211-217.
99. Lawrence R, Chang LJ, Siebenlist U, Bressler P, Soncnshcin GE: Vascular smooth muscle cells express a constitutive NF-icB activity, J Biol Chem 1994;269:28913-28918.
100. Bellas RE, Lee JS, Soncnshcin GE: Expression of a constitutive NF-kappa B-like activity;s essential for proliferation of cultured bovine vascular smooth muscle cells, J Clin Invest 1995:96:2521-2527.
101. Lemstrom KB, Aho PT, Bruggeman CA, Hayry PJ: Cytomegalovirus infection enhances mRNA expression of platelet-derived growth factor-BB and transforming growth faclor-beta I in rat aortic allografts, Possible mechanism for cytomegalovirus-cnhanccd graft arteriosclerosis, Arterioscler Thromb 1994:14:2043-2052.
102. Kapasi K, Rice GPA: Cytomegalovirus infection of peripheral blood mononuclear cells: Effects on intcrlcukin-1 and -2 production and responsiveness, J Virol 1988:62:3603- 3607.
103. Woodroffe SB, Garnett HM, Danis VA: Interleukin-1 production and cell-activation response to cytomegalovirus infection of vascular endothelial cells, Arch Virol 1993:133: 295-308.
104. Muravama T, Kuno K, Jisaki F, Obuchi M, Sakamuro D, Furukawa T, Mukaida N, Matsushima K: Enhancement of human cytomegalovirus replication in a human lung fibroblast cell line by interleukin-8. J Virol 1994: 68:7582-7585.
105. Haagmans BL, Stals FS, Van der Meide PH, Bruggeman CA, Horzinek MC, Schijns VECJ: Tumor necrosis factor alpha promotes replication and pathogenicity of rat cytomegalovirus, J Virol 1994:68:2297-2304.
106. Stein J, Volk HD, Liebcnthal C, Kruger DH, Prosch S: Tumour necrosis factor alpha stimulates the activity of the human cytomegalovirus major immediate early enhancer/promoter in immature monocytic cells, J Gen Virol 1993:74:2333-2338.
107. Prösch S, Staak K, Stein J, Liebcnthal C, Stamminger T, Volk HD, Kruger DH: Stimulation of the human cytomegalovirus IE enhancer promoter in HL-60 cells by TNF-a is mediated via induction of NF-kB, Virology 1995;208:197-206.
108. Fietze E, Prösch S, Rcinke P, Stein J, Docke WD, StafTa G, Löning S, Dcvaux S, Emmrich
109. F, Von Baehr R, Krüger DH, Volk HD: Cytomegalovirus infection in transplant recipients, Transplantation 1994.58:675-680.
110. Span AHM, Mullers W, Miltenburg AMM, Bruggeman CA: Cytomegalovirus induced PMN adherence in relation to an ELAM-1 antigen present on infected endothelial cell monolayers, Immunology 1991;72:355-360.
111. Sedmak DD, Knight DA, Vook NC, Wald-man JW: Divergent patterns of ELAM-1. ICAM-1. and VCAM-I expression on cytomegalovirus-infected endothelial cells, Trans-plantation 1994;58:1379-1385.
112. Geist LJ, Hunninghakc GW: Cytomegalovirus as a t rans-activator of cellular genes, Semin Virol 1994:5:415-420.
113. Alcami J, Paya CV, Virelizicr JL, Michclson S: Antagonistic modulation of human cytomegalovirus replication by transforming growth factor (i and basic fibroblastic growth factor, J Gen Virol 1993:74:269-274.
114. Karupiah G, Xie QW, Buller RM, Nathan C, Duarte C, MacMicking JD: Inhibition of viral replication by intcrfcron-gamma-induced nitric oxide synthase, Science 1993:261:1445- 1448.
115. Gribaudo G, Ravaglia S, Gaboli M, Gariglio M, Cavallo R, Landolfo S: Interferon-alpha inhibits the murine cytomegalovirus immediate-early gene expression by down-regulating NF-kappa B activity, Virologv 1995:211: 251-260.
116. Droge W, Eck HP, Mihm S: HIV-induced cysteine deficiency andT-cell dysfunction - A rationale for treatment with N-acctylcysteinc, Immunol Today 1992;13:211-214.
117. Favier A, Sappev C, Leclerc P, Faurc P, Mi-coud M: Antioxidant status and lipid peroxidation in patients infected with HIV, Chem Biol Interact 1994:91:165-180.
118. Palamara AT, Pcrno CF, Ciriolo MR, Dini L, Balestra E, D'Agostini C, Di Francesco P, Favalli C, Rotilio G, Garaci E: Evidence for antiviral activity of glutathione, In vitro inhibition of herpes simplex virus type I replication, Antiviral Res 1995:27:237-253.
119. C'roen KD: Evidence for antiviral effect of nitric oxide, Inhibition of herpes simplex virus type I replication, J Clin Invest 1993;91: 2446-2452.
120. Mclkova Z, Esteban M: Inhibition of vaccinia virus DNA replication by inducible expression of nitric oxide synthase, J Immunol 1995:155:5711-5718.
121. Jacoby DB, Choi AM: Influenza virus induces expression of antioxidanl genes in human epithelial cells, Free Radic Biol Med 1994;16:821-824.
122. Nabel G, Baltimore D: An inducible transcription factor activates expression of human immunodeficiency virus in T cells, Nature 1987;326:711-713.
123. Gougerot-Pocidalo MA, Aillet F, Virelizicr JL, Israel N: Influence of redox status of lymphocytes and monocytes on HIV transcription and replication, Immunobiology 1995: 193:204-209.
124. Pircl B, Legrand Pools S, Sappev C, Piette J: NF-kappa B transcriptional factor and human immunodeficiency virus type I (HIV-1) activation by methylene blue photosensitization, EurJ Biochem 1995:228:447-455.
125. Roedercr M, Ela SW, Staal FJ, Herzenberg LA, N-acetylcystcinc: A new approach to anti-HIV therapy, AIDS Res Hum Retroviruses 1992:8:209-217.
126. Cinatl J, Weber B, Rabenau H, Gumbcl HO, Chcnot JF, Scholz M, Fnckc A, Doerr HW: In vitro inhibition of human cytomegalovirus replication in human foreskin fibroblasts and endothelial cells by ascorbic acid 2-phosphate, Antiviral Res 1995:27:405-418.
127. Grilli M, Chiu JS, Lcnardo MJ: NF-kappa B anc Rel: Participants in a multiform transcriptional regulatory system, lnt Cytol 1993; 143:1-62.
128. Boldogh I, Fons MP, Albrecht T: Increased levels of sequence-specific DNA-binding proteins in human cvtomegalovirus-infcctcd cells, Biochem Biophys Res Commun 1993; 197:1505-1010.
129. Yurochko AD, Kowalik TF, Huong SM, Huang ES: Human cytomegalovirus upregu-lates NF-kappa B activity by transactivating the NF-kappa B pl05/p50 and p65 promoters, J Virol 1995:69:5391-5400.